Helicobacter pylori-related non-coding RNAs in gastric cancer screening: Emerging evidence and translational challenges
Abstract
Gastric cancer (GC) has high morbidity and mortality worldwide. Due to the absence of noticeable symptoms, diagnosing GC at an early stage is very difficult, which consequently leads to advanced GC and poor prognosis. Effective biomarkers are essential for prolonging patients' survival. Helicobacter pylori (H. pylori) infection represents the most significant risk factor for GC, with nearly all cases linked to this infection. Many non-coding RNAs (ncRNAs) are dysregulated in H. pylori-infected GC, indicating that ncRNAs may serve as biomarkers of early-stage GC. In this editorial, we discuss the study by Chen et al. Although previous studies have identified roles for miR-136 in gastric cancer proliferation, apoptosis, and invasion, none have specifically explored its relationship with H. pylori-associated gastric carcinogenesis.
Read the paper
Related studies
- Regulation of nucleolus assembly by non-coding RNA polymerase II transcripts
- For a Healthy Histone Code, a Little SUMO in the Tail Keeps the Acetyl Away
- Discovering a binary CTCF code with a little help from BORIS
- Article Commentary: Stabilizing the Code–-Methods to Preserve RNA Prove Their Worth
- Foreword to the Special Issue for the RINTC (The Implicit Seismic Risk of Code-Conforming Structures) Project
- Commentary: Promoting Health and Well-being in Pediatric Primary Care Settings: Using Health and Behavior Codes at Routine Well-child Visits
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.